Empire One: First-In-Human Study Of A New Transcatheter Aortic Valve System - Pcr London Valves 2024

Empire one: first-in-human study of a new transcatheter aortic valve system - PCR London Valves 2024

PCR

New frontiers in TAVI: have we reached them? PCR London Valves 2024

PCR

From index procedure to re-valving with a novel self-expanding valve - PCR London Valves 2024

PCR

See the heart like never before at PCR London Valves 2024

PCR

Transforming interventional care for patients with mitral regurgitation - PCR London Valves 2024

PCR

Transfemoral TAVI access using intravascular lithotripsy in challenging peripheral vascular disease

PCR

Who are eligible patients for transcatheter mitral valve replacement? - PCR London Valves 2023

PCR

Is only fixing functional MR in heart failure patients enough? PCR London Valves 2023

PCR

PART 1 - Best long-term outcomes start with the first procedure - PCR London Valves 2021

PCR

Transcatheter mitral valve replacement: from planning to final assessment - PCR London Valves 2022

PCR

Nina Wunderlich shares why #PCRLV 2024 is the place to be

PCR

Introducing the first PCR London Valves 2022 Fellows TAVI Course!

PCR

The science behind a valve designed for life - PCR London Valves 2021

PCR

Tailoring tricuspid interventions with the EVOQUE and PASCAL Precision systems - PCR London Valves

PCR

The remaining big questions in transcatheter tricuspid valve intervention - PCR London Valves 2023

PCR

Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR™)

PCR

PCR London Valves 2022 – What’s on this year?

PCR

Remaining unmet needs and strategies in TAVI - PCR London Valves 2022

PCR